New vaccine trial to prevent melanoma cancer

Published: June 4, 2024, 1:38 p.m.

The world\u2019s first personalised mRNA cancer vaccine for melanoma halves the risk of patients dying or the disease. 

Melanoma affects more than 150,000 people a year globally, according to 2020 figures from World\u202fCancer\u202fResearch Fund International. 

Kingston Mills is a Professor of Experimental Immunology and Biochemistry at Trinity College Dublin and joins Se\xe1n to discuss.